Literature DB >> 11855557

Dopaminergic control of renal tubular function in patients with compensated cirrhosis.

Giovanni Sansoè1, Alberto Ferrari, Enrica Baraldi, Carmen Nives Castellana, Alessandra Biava, Stefano Silvano, Floriano Rosina, Lorenzo Bonardi, Federico Manenti.   

Abstract

In normal humans, plasma dopamine levels rise during head-out water immersion or saline intravenous infusion. Dopamine inhibits Na+,K+-ATPase activity in the proximal tubule and blunts aldosterone secretion leading to increased diuresis and natriuresis. The aim of this study is to evaluate the role of endogenous dopaminergic activity in the intrarenal sodium handling in patients with compensated liver cirrhosis. We studied nine healthy controls and 12 patients with Child-Pugh A cirrhosis during a normosodic diet for (1) dopaminergic activity, as measured by the incremental aldosterone responses 30 and 60 min after intravenous metoclopramide administration; (2) basal plasma levels of active renin and aldosterone; (3) 4-hr renal clearance of lithium (an index of fluid delivery to the distal tubule), creatinine, sodium, and potassium, first without and then with dopaminergic blockade with intravenous metoclopramide. The patients displayed greater endogenous dopaminergic activity, evidenced by higher incremental aldosterone responses compared with controls (+30 min: 160.2 +/- 68.8 vs 83.6 +/- 35.2 pg/ml, P < 0.01; +60 min: 140.5 +/- 80.3 vs 36.8 +/- 39.1 pg/ml, P < 0.01, respectively). In spite of this, patients and controls did not show significantly different basal aldosterone plasma levels, delivery of sodium to the distal nephron, or urinary excretion of sodium. In both groups the dopaminergic blockade with metoclopramide determined no change in sodium and potassium urinary excretion, but it caused a fall of the fluid and sodium delivery from the proximal tubule to the distal nephron among the patients (from 30.7 +/- 9.3 to 14.4 +/- 4.5 ml/min, P < 0.001; and from 4.25 +/- 1.30 to 2.00 +/- 0.64 meq/min, P < 0.001, respectively). In this group the natriuresis was maintained due to a reduction of the reabsorbed fraction of the distal sodium delivery (from 97.5 +/- 1.9% to 89.8 +/- 12.4%, P < 0.05). In conclusions, compensated cirrhotic patients display an increased endogenous dopaminergic activity compared with controls. This function is critical in maintaining the delivery of sodium to the distal nephron.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11855557     DOI: 10.1023/a:1013738626256

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  51 in total

1.  EFFECT OF DOPAMINE IN MAN: AUGMENTATION OF SODIUM EXCRETION, GLOMERULAR FILTRATION RATE, AND RENAL PLASMA FLOW.

Authors:  R H MCDONALD; L I GOLDBERG; J L MCNAY; E P TUTTLE
Journal:  J Clin Invest       Date:  1964-06       Impact factor: 14.808

2.  Changes in plasma renin activity in cirrhosis: a reappraisal based on studies in 67 patients and "low-renin" cirrhosis.

Authors:  S P Wilkinson; I K Smith; R Williams
Journal:  Hypertension       Date:  1979 Mar-Apr       Impact factor: 10.190

3.  Effects of dopamine on renal function in patients with cirrhosis.

Authors:  D E Barnardo; W P Baldus; F T Maher
Journal:  Gastroenterology       Date:  1970-04       Impact factor: 22.682

4.  Dopaminergic modulation of aldosterone responsiveness to angiotensin II with changes in sodium intake.

Authors:  M B Gordon; T J Moore; R G Dluhy; G H Williams
Journal:  J Clin Endocrinol Metab       Date:  1983-02       Impact factor: 5.958

5.  Physiological significance of plasma sulfoconjugated dopamine: experimental and clinical studies.

Authors:  M Yoshizumi; Y Ishimura; Y Masuda; T Ohuchi; I Katoh; H Houchi; M Oka
Journal:  Hypertens Res       Date:  1995-06       Impact factor: 3.872

6.  Dopamine inhibits the aldosterone response to upright posture.

Authors:  C D Malchoff; J Hughes; S Sen; S Jackson; R M Carey
Journal:  J Clin Endocrinol Metab       Date:  1986-07       Impact factor: 5.958

Review 7.  Dopamine: receptors and clinical applications.

Authors:  L I Goldberg
Journal:  Clin Physiol Biochem       Date:  1985

8.  Does dopamine regulate aldosterone secretion in the rat?

Authors:  G C Inglis; C J Kenyon; J A Hannah; J M Connell; S G Ball
Journal:  Clin Sci (Lond)       Date:  1987-07       Impact factor: 6.124

9.  Aldosterone related blood volume expansion in cirrhosis before and during the early phase of ascites formation.

Authors:  M Bernardi; F Trevisani; C Santini; R De Palma; G Gasbarrini
Journal:  Gut       Date:  1983-08       Impact factor: 23.059

10.  Zona fasciculata-like cells determine the response of plasma aldosterone to metoclopramide and aldosterone synthase messenger ribonucleic acid level in aldosterone-producing adenoma.

Authors:  K D Wu; Y M Chen; J S Chu; K Y Hung; T S Hsieh; B S Hsieh
Journal:  J Clin Endocrinol Metab       Date:  1995-03       Impact factor: 5.958

View more
  1 in total

1.  Renal tubular events following passage from the supine to the standing position in patients with compensated liver cirrhosis: loss of tubuloglomerular feedback.

Authors:  G Sansoè; A M Biava; S Silvano; A Ferrari; F Rosina; A Smedile; A Touscoz; L Bonardi; M Rizzetto
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.